Lv11
30 积分 2025-02-27 加入
Discovery of a Potent and Selective CCR8 Small Molecular Antagonist IPG7236 for the Treatment of Cancer
1小时前
待确认
Discovery of CCR8 Antagonist IDOR‐1136‐5177 for the Treatment of Cancer
3小时前
已完结
GPCR drug discovery: new agents, targets and indications
4小时前
已完结
Genetically encoding phosphotyrosine and its nonhydrolyzable analog in bacteria
2个月前
已完结
RNA therapeutics: updates and future potential
2个月前
已完结
The targeted protein degradation landscape
3个月前
已完结
Abstract ND02: Discovery of BMS-986365, a ligand-directed androgen receptor degrader (AR LDD) with a dual mechanism-of-action and best-in-class potential, for the treatment of advanced prostate cancer
3个月前
已关闭
Targeted protein degradation for cancer therapy
3个月前
已完结
TGF-β receptors: In and beyond TGF-β signaling
3个月前
已完结
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
3个月前
已完结
皖公网安备34019202002308
